Article(id=1329529021777424822, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329529021181833654, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2024.07.001, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1690041600000, receivedDateStr=2023-07-23, revisedDate=1691424000000, revisedDateStr=2023-08-08, acceptedDate=null, acceptedDateStr=null, onlineDate=1794914020246, onlineDateStr=2026-11-17, pubDate=1720540800000, pubDateStr=2024-07-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794914020246, onlineIssueDateStr=2026-11-17, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794914020246, creator=13701087609, updateTime=1794914020246, updator=13701087609, issue=Issue{id=1329529021181833654, tenantId=1146029695717560320, journalId=1319690329412173987, year='2024', volume='45', issue='7', pageStart='697', pageEnd='798', issueExtLink='null', onlineDate='null', pubDate='1720540800000', pubDateStr='2024-07-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794914020104, creator='13701087609', updateTime=1794988140586, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1329839905410233043, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329529021181833654, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1329839905410233044, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329529021181833654, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=697, endPage=702, ext={EN=ArticleExt(id=1329529023065076151, articleId=1329529021777424822, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Progress in the clinical application of all-trans-retinoic acid in solid tumors, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

All-trans-retinoic acid (ATRA) is the clinical choice for the treatment of acute promyelocytic leukemia. However, in recent years, a large number of studies have shown that ATRA maintains the human normal immune microenvironment by inhibiting the immune escape effect of tumor stem cells and promoting the differentiation of myeloid-derived suppressor cells, and enhances the efficacy of chemotherapeutic drugs, targeted drugs and immunotherapy drugs in solid tumors. This paper reviewed the clinical trial progress of ATRA in solid tumors to provide a reference for its further clinical application.

, authors=Cong RUAN1, Jiajia QIAN1, Qiong DU1, 2, 3, Qing ZHAI1, 2, 3, Xiaomin SUN4, Rui XU1, *, authorsList=Cong RUAN, Jiajia QIAN, Qiong DU, Qing ZHAI, Xiaomin SUN, Rui XU, authorCompany=null, correspAuthors=Rui XU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329529023442563512, articleId=1329529021777424822, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=全反式维甲酸在实体瘤中临床应用进展, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=

全反式维甲酸(all-trans-retinoic acid,ATRA)是治疗急性早幼粒细胞白血病(acute promyelocytic leukemia)的临床首选药物。然而近年来大量研究表明,ATRA可通过抑制肿瘤干细胞的免疫逃逸效应以及促进髓源性抑制细胞的分化等机制来维持人体正常免疫微环境,进而增强化疗、靶向和免疫治疗药物在实体瘤中的疗效。该文就ATRA在实体瘤中的临床研究进展作一综述,为其进一步临床应用提供参考。

, authors=阮聪1, 钱佳佳1, 杜琼1, 2, 3, 翟青1, 2, 3, 孙晓敏4, 徐蕊1, *, authorsList=阮聪, 钱佳佳, 杜琼, 翟青, 孙晓敏, 徐蕊, authorCompany=null, correspAuthors=徐蕊, authorNote=

阮聪,药师,研究方向:肿瘤内分泌药物治疗管理。

, correspAuthorsNote=
徐蕊,主管药师,研究方向:肿瘤药学。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=snwzc9IE6gNCMYRQtd/cJw==, magXml=SjJTfzg+SpJzMTfV6LvcYQ==, pdfUrl=null, pdf=3TCzNzSGawVm/hlUIWna3A==, pdfFileSize=1548342, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=5K6fAJWWnolThGQx4w3v9g==, mapNumber=null, fund=null)}, authors=[Author(id=1329529024025571782, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529024096874952, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529024025571782, language=EN, stringName=Cong RUAN, firstName=Cong, middleName=null, lastName=RUAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529024159789513, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529024025571782, language=CN, stringName=阮聪, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.复旦大学附属肿瘤医院闵行分院药剂科,上海 200240, bio={"content":"

阮聪,药师,研究方向:肿瘤内分泌药物治疗管理。

"}, bioImg=null, bioContent=

阮聪,药师,研究方向:肿瘤内分泌药物治疗管理。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529023669055929, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=1., ext=[AuthorCompanyExt(id=1329529023677444538, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023669055929, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China), AuthorCompanyExt(id=1329529023685833147, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023669055929, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属肿瘤医院闵行分院药剂科,上海 200240)])]), Author(id=1329529024231092683, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529024302395853, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529024231092683, language=EN, stringName=Jiajia QIAN, firstName=Jiajia, middleName=null, lastName=QIAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529024373699022, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529024231092683, language=CN, stringName=钱佳佳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.复旦大学附属肿瘤医院闵行分院药剂科,上海 200240, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529023669055929, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=1., ext=[AuthorCompanyExt(id=1329529023677444538, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023669055929, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China), AuthorCompanyExt(id=1329529023685833147, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023669055929, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属肿瘤医院闵行分院药剂科,上海 200240)])]), Author(id=1329529024440807888, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529024533082580, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529024440807888, language=EN, stringName=Qiong DU, firstName=Qiong, middleName=null, lastName=DU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China
2.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China
3.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529024625357269, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529024440807888, language=CN, stringName=杜琼, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.复旦大学附属肿瘤医院闵行分院药剂科,上海 200240
2.复旦大学附属肿瘤医院药剂科,上海 200032
3.复旦大学上海医学院肿瘤学系,上海 200032, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529023669055929, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=1., ext=[AuthorCompanyExt(id=1329529023677444538, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023669055929, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China), AuthorCompanyExt(id=1329529023685833147, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023669055929, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属肿瘤医院闵行分院药剂科,上海 200240)]), AuthorCompany(id=1329529023752942012, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=2., ext=[AuthorCompanyExt(id=1329529023761330621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023752942012, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China), AuthorCompanyExt(id=1329529023769719230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023752942012, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学附属肿瘤医院药剂科,上海 200032)]), AuthorCompany(id=1329529023849411007, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=3., ext=[AuthorCompanyExt(id=1329529023861993920, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023849411007, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China), AuthorCompanyExt(id=1329529023870382529, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023849411007, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.复旦大学上海医学院肿瘤学系,上海 200032)])]), Author(id=1329529024709243351, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529024818295259, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529024709243351, language=EN, stringName=Qing ZHAI, firstName=Qing, middleName=null, lastName=ZHAI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China
2.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China
3.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529024881209820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529024709243351, language=CN, stringName=翟青, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.复旦大学附属肿瘤医院闵行分院药剂科,上海 200240
2.复旦大学附属肿瘤医院药剂科,上海 200032
3.复旦大学上海医学院肿瘤学系,上海 200032, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529023669055929, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=1., ext=[AuthorCompanyExt(id=1329529023677444538, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023669055929, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China), AuthorCompanyExt(id=1329529023685833147, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023669055929, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属肿瘤医院闵行分院药剂科,上海 200240)]), AuthorCompany(id=1329529023752942012, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=2., ext=[AuthorCompanyExt(id=1329529023761330621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023752942012, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China), AuthorCompanyExt(id=1329529023769719230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023752942012, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学附属肿瘤医院药剂科,上海 200032)]), AuthorCompany(id=1329529023849411007, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=3., ext=[AuthorCompanyExt(id=1329529023861993920, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023849411007, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China), AuthorCompanyExt(id=1329529023870382529, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023849411007, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.复旦大学上海医学院肿瘤学系,上海 200032)])]), Author(id=1329529024944124382, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529025036399072, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529024944124382, language=EN, stringName=Xiaomin SUN, firstName=Xiaomin, middleName=null, lastName=SUN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=4, address=4.Shandong LONGFINE Pharmaceutical Co., Ltd., Jining 272600, Shandong Province China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529025128673761, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529024944124382, language=CN, stringName=孙晓敏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=4, address=4.山东良福制药有限公司,山东 济宁 272600, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529023924908482, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=4., ext=[AuthorCompanyExt(id=1329529023933297091, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023924908482, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.Shandong LONGFINE Pharmaceutical Co., Ltd., Jining 272600, Shandong Province China), AuthorCompanyExt(id=1329529023937491396, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023924908482, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.山东良福制药有限公司,山东 济宁 272600)])]), Author(id=1329529025195782627, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329529025271280101, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529025195782627, language=EN, stringName=Rui XU, firstName=Rui, middleName=null, lastName=XU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529025346777574, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529025195782627, language=CN, stringName=徐蕊, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.复旦大学附属肿瘤医院闵行分院药剂科,上海 200240, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529023669055929, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=1., ext=[AuthorCompanyExt(id=1329529023677444538, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023669055929, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China), AuthorCompanyExt(id=1329529023685833147, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023669055929, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属肿瘤医院闵行分院药剂科,上海 200240)])])], keywords=[Keyword(id=1329529025439052263, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, language=EN, orderNo=1, keyword=all-trans-retinoic acid), Keyword(id=1329529025518744040, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, language=EN, orderNo=2, keyword=solid tumor), Keyword(id=1329529025581658601, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, language=EN, orderNo=3, keyword=tumor stem cells), Keyword(id=1329529025657156074, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, language=EN, orderNo=4, keyword=myeloid-derived suppressor cells), Keyword(id=1329529025715876331, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, language=EN, orderNo=5, keyword=immunomodulation), Keyword(id=1329529025778790892, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, language=CN, orderNo=1, keyword=全反式维甲酸), Keyword(id=1329529025837511149, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, language=CN, orderNo=2, keyword=实体瘤), Keyword(id=1329529025900425710, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, language=CN, orderNo=3, keyword=肿瘤干细胞), Keyword(id=1329529025971728879, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, language=CN, orderNo=4, keyword=髓源性抑制细胞), Keyword(id=1329529026043032048, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, language=CN, orderNo=5, keyword=免疫调节)], refs=[Reference(id=1329529026340827635, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Gudas LJ. Retinoids retinoic acid receptors and cancer[J]. Toxicology, 2001, 164(1-3): 11., articleTitle=null, refAbstract=null), Reference(id=1329529026420519412, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Huang ME, Ye YC, Chen SR, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia[J]. Blood, 1988, 72(2): 567-572., articleTitle=null, refAbstract=null), Reference(id=1329529026512794101, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Lei MML, Lee TKW. Cancer stem cells: emerging key players in immune evasion of cancers[J]. Front Cell Dev Biol, 2021, 9: 692940., articleTitle=null, refAbstract=null), Reference(id=1329529026592485878, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=Chulpanova DS, Rizvanov AA, Solovyeva VV. The role of cancer stem cells and their extracellular vesicles in the modulation of the antitumor immunity[J]. Int J Mol Sci, 2022, 24(1): 395., articleTitle=null, refAbstract=null), Reference(id=1329529026667983351, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhao J. Cancer stem cells and chemoresistance: the smartest survives the raid[J]. Pharmacol Ther, 2016, 160: 145-158., articleTitle=null, refAbstract=null), Reference(id=1329529026735092217, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Moreb JS, Ucar-Bilyeu DA, Khan A. Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells[J]. Cancer Chemothe Pharmacol, 2017, 79(2): 295-301., articleTitle=null, refAbstract=null), Reference(id=1329529026823172602, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Bi G, Liang J, Bian Y, et al. The immunomodulatory role of all-trans retinoic acid in tumor microenvironment[J]. Clin Exp Med, 2023, 23(3), 591-606., articleTitle=null, refAbstract=null), Reference(id=1329529026894475771, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Nefedova Y, Fishman M, Sherman S, et al. Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells[J]. Cancer Res, 2007, 67(22): 11021-11028., articleTitle=null, refAbstract=null), Reference(id=1329529027062247932, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023[J]. CA Cancer J Clin, 2023, 73(1): 17-48., articleTitle=null, refAbstract=null), Reference(id=1329529027154522621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Makowski P, Pacholczyk M, Agiewska B, et al. Hepatocellular carcinoma-epidemiology and treatment[J]. Przegl Epidemiol, 2006, 60(4): 731-740., articleTitle=null, refAbstract=null), Reference(id=1329529027217437182, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Belghiti J, Kianmanesh R. Surgical treatment of hepatocellular carcinoma[J]. HPB (Oxford), 2005, 7: 42-49., articleTitle=null, refAbstract=null), Reference(id=1329529027347460607, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Lee PH, Lin WJ, Tsang YM, et al. Clinical management of recurrent hepatocellular carcinoma[J]. Ann Surg, 1995, 222(5): 670-676., articleTitle=null, refAbstract=null), Reference(id=1329529027431346688, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Tanaka S, Arii S. Molecularly targeted therapy for hepatocellular carcinoma[J]. Cancer Sci, 2009, 100(1): 1-8., articleTitle=null, refAbstract=null), Reference(id=1329529027523621377, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Zhang Y, Guan DX, Shi J, et al. All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancer[J]. J Hepatol, 2013, 59(6): 1255-1263., articleTitle=null, refAbstract=null), Reference(id=1329529027607507458, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Sun J, Liu H, Shi J, et al. All-trans retinoic acid combined with oxaliplatin suppressed proliferation of chemo-resistant hepatocellular carcinoma cells by inducing G2/M cell cycle arrest[J]. Termedia Publishing House, 2021., articleTitle=null, refAbstract=null), Reference(id=1329529027666227715, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Sun J, Liu C, Shi J, et al. A novel chemotherapy strategy for advanced hepatocellular carcinoma: a multicenter retrospective study[J]. Chin Med J (Engl), 2022, 135(19): 2338-2343., articleTitle=null, refAbstract=null), Reference(id=1329529027733336580, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=Sun J, Liu C, Wang N, et al. All-trans-retinoic acid plus oxaliplatin/fluorouracil/leucovorin for advanced hepatocellular carcinoma with pulmonary metastasis: a multicenter retrospective study[J]. Cancer Manag Res, 2022, 14: 1663-1670., articleTitle=null, refAbstract=null), Reference(id=1329529027808834053, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Ghosn M, Kourie HR, El Karak F, et al. Optimum chemotherapy in the management of metastatic pancreatic cancer[J]. World J Gastroenterol, 2014, 20(9): 2352-2357., articleTitle=null, refAbstract=null), Reference(id=1329529027871748614, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=Ohmine K, Kawaguchi K, Ohtsuki S, et al. Quantitative targeted proteomics of pancreatic cancer: deoxycytidine kinase protein level correlates to progression-free survival of patients receiving gemcitabine treatment[J]. Mol Pharm, 2015, 12(9): 3282-3291., articleTitle=null, refAbstract=null), Reference(id=1329529027943051783, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=Kuroda H, Tachikawa M, Uchida Y, et al. All-trans retinoic acid enhances gemcitabine cytotoxicity in human pancreatic cancer cell line AsPC-1 by up-regulating protein expression of deoxycytidine kinase[J]. Eur J Pharm Sci, 2017, 30: 116-121., articleTitle=null, refAbstract=null), Reference(id=1329529028005966344, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=Kocher HM, Basu B, Froeling FEM, et al. Phase Ⅰ clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer[J]. Nat Commun, 2020, 11(1): 4841., articleTitle=null, refAbstract=null), Reference(id=1329529028077269513, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=Nguyen PH, Giraud J, Staedel C, et al. All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth[J]. Oncogene, 2016, 35(43): 5619-5628., articleTitle=null, refAbstract=null), Reference(id=1329529028152766986, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=胡孔旺, 孟翔凌, 杨文奇, 等. 全反式维甲酸及腹腔化疗对进展期胃癌手术后患者生存期的影响[J]. 肿瘤, 2013, 33(6): 550-555., articleTitle=null, refAbstract=null), Reference(id=1329529028224070155, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=Lieberman DA, Rex DK, Winawer SJ, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer[J]. Gastroenterology, 2012, 143(3): 844-857., articleTitle=null, refAbstract=null), Reference(id=1329529028299567628, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=Guinney J, Dienstmann R, Wang X, et al. The consensus molecular subtypes of colorectal cancer[J]. Nat Med, 2015, 21(11): 1350-1356., articleTitle=null, refAbstract=null), Reference(id=1329529028375065101, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=Liu W, Song Y, Zhang C, et al. The protective role of all-transretinoic acid (ATRA) against colorectal cancer development is achieved via increasing miR-3666 expression and decreasing E2F7 expression[J]. Biomed Pharmacother, 2018, 104: 94-101., articleTitle=null, refAbstract=null), Reference(id=1329529028437979662, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=尤振宇, 刘洋, 苏晓辉, 等. 全反式维甲酸联合化疗治疗晚期结肠癌临床观察[J]. 现代生物医学进展, 2015, 15(13): 2478-2482., articleTitle=null, refAbstract=null), Reference(id=1329529028505088527, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Kleiner DE, Stetler-Stevenson WG. Matrix metalloproteinases and metastasis[J]. Cancer Chemother Pharmacol, 1999, 43(Suppl): S42-S51., articleTitle=null, refAbstract=null), Reference(id=1329529028584780304, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=Dutta A, Sen T, Banerji A, et al. Studies on multifunctional effect of all-trans retinoic acid (ATRA) on matrix metalloproteinase-2 (MMP-2) and its regulatory molecules in human breast cancer cells (MCF-7)[J]. J Oncol, 2009, 2009: 627840., articleTitle=null, refAbstract=null), Reference(id=1329529028656083473, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=Bryan M, Pulte ED, Toomey KC, et al. A pilot phase Ⅱ trial of all-trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer[J]. Invest New Drugs, 2011, 29(6): 1482-1487., articleTitle=null, refAbstract=null), Reference(id=1329529028718998034, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=Manna SK, Aggarwal BB. All-trans-retinoic acid upregulates TNF receptors and potentiates TNF-induced activation of nuclear factors-κB, activated protein-1 and apoptosis in human lung cancer cells[J]. Oncogene, 2000, 19(17): 2110-2119., articleTitle=null, refAbstract=null), Reference(id=1329529028781912595, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=Moro M, Bertolini G, Pastorino U, et al. Combination treatment with all-trans retinoic acid prevents cisplatin-induced enrichment of CD133+ tumor-initiating cells and reveals heterogeneity of cancer stem cell compartment in lung cancer[J]. J Thorac Oncol, 2015, 10(7): 1027-1036., articleTitle=null, refAbstract=null), Reference(id=1329529028874187284, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=Conley BA, Egorin MJ, Sridhara R, et al. Phase Ⅰclinical trial of all-trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamics[J]. Cancer Chemother Pharmacol, 1997, 39(4): 291-299., articleTitle=null, refAbstract=null), Reference(id=1329529028953879061, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=Arrieta O, González-De la Rosa CH, Aréchaga-Ocampo E, et al. Randomized phase Ⅱ trial of All-trans-retinoic acid with chemotherapy based on paclitaxel and cisplatin as first-line treatment in patients with advanced non-small-cell lung cancer[J]. J Clin Oncol, 2010, 28(21): 3463-3471., articleTitle=null, refAbstract=null), Reference(id=1329529029046153750, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=Kokemueller H, Eckardt A, Brachvogel P, et al. Adenoid cystic carcinoma of the head and neck-a 20 years experience[J]. Int J Oral Maxillofac Surg, 2004, 33(1): 25-31., articleTitle=null, refAbstract=null), Reference(id=1329529029125845527, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=Lloyd S, Yu JB, Wilson LD, et al. Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy[J]. Am J Clin Oncol, 2011, 34(1): 76-81., articleTitle=null, refAbstract=null), Reference(id=1329529029230703128, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=Ellington CL, Goodman M, Kono SA, et al. Adenoid cystic carcinoma of the head and neck: incidence and survival trends based on 1973—2007 surveillance, epidemiology, and end results data[J]. Cancer, 2012, 118(18): 4444-4451., articleTitle=null, refAbstract=null), Reference(id=1329529029314589209, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=Dillon PM, Chakraborty S, Moskaluk CA, et al. Adenoid cystic carcinoma: a review of recent advances, molecular targets, and clinical trials[J]. Head Neck, 2016, 38(4): 620-627., articleTitle=null, refAbstract=null), Reference(id=1329529029432029722, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=Mandelbaum J, Shestopalov IA, Henderson RE, et al. Zebrafish blastomere screen identifies retinoic acid suppression of MYB in adenoid cystic carcinoma[J]. J Exp Med, 2018, 215(10): 2673-2685., articleTitle=null, refAbstract=null), Reference(id=1329529029524304411, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=Hanna GJ, ONeill A, Cutler JM, et al. A phase Ⅱ trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma[J]. Oral Oncol, 2021, 119: 105366., articleTitle=null, refAbstract=null), Reference(id=1329529029612384796, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=Ye L, Zhang L, Li R, et al. Combined all-trans retinoic acid with low-dose apatinib in treatment of recurrent/metastatic head and neck adenoid cystic carcinoma: a single-center, secondary analysis of a phase Ⅱ study[J]. Cancer Med, 2023, 12(8): 9144-9155., articleTitle=null, refAbstract=null), Reference(id=1329529029687882269, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=Tobin RP, Jordan KR, Robinson WA, et al. Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with ipilimumab[J]. Int Immunopharmacol, 2018, 63: 282-291., articleTitle=null, refAbstract=null), Reference(id=1329529029754991134, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=Tobin RP, Cogswell DT, Cates VM, et al. Targeting MDSC differentiation using ATRA: a phase Ⅰ/Ⅱ clinical trial combining pembrolizumab and all-trans retinoic acid for metastatic melanoma[J]. Clin Cancer Res, 2023, 29(7): 1209-1219., articleTitle=null, refAbstract=null)], funds=[Fund(id=1329529026156278257, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, awardId=MWYJYX03, language=CN, fundingSource=上海市闵行区卫生健康系统优秀青年药学人才计划(MWYJYX03), fundOrder=null, country=null), Fund(id=1329529026227581426, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, awardId=2022MHZ040, language=CN, fundingSource=上海市闵行区自然科学研究课题(2022MHZ040), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1329529023669055929, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=1., ext=[AuthorCompanyExt(id=1329529023677444538, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023669055929, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China), AuthorCompanyExt(id=1329529023685833147, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023669055929, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属肿瘤医院闵行分院药剂科,上海 200240)]), AuthorCompany(id=1329529023752942012, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=2., ext=[AuthorCompanyExt(id=1329529023761330621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023752942012, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China), AuthorCompanyExt(id=1329529023769719230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023752942012, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学附属肿瘤医院药剂科,上海 200032)]), AuthorCompany(id=1329529023849411007, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=3., ext=[AuthorCompanyExt(id=1329529023861993920, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023849411007, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China), AuthorCompanyExt(id=1329529023870382529, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023849411007, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.复旦大学上海医学院肿瘤学系,上海 200032)]), AuthorCompany(id=1329529023924908482, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=4., ext=[AuthorCompanyExt(id=1329529023933297091, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023924908482, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.Shandong LONGFINE Pharmaceutical Co., Ltd., Jining 272600, Shandong Province China), AuthorCompanyExt(id=1329529023937491396, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023924908482, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.山东良福制药有限公司,山东 济宁 272600)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.07.001, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2024.07.001, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2024.07.001, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2024.07.001, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1720540800000, fullTextJson=null, articleText=null, reference=null)
收藏切换
全反式维甲酸在实体瘤中临床应用进展
阮聪 1 , 钱佳佳 1 , 杜琼 1, 2, 3 , 翟青 1, 2, 3 , 孙晓敏 4 , 徐蕊 1, *
世界临床药物 | 医药专论 2024,45(7): 697-702
收起
收藏切换
世界临床药物 |医药专论 2024 , 45 (7) : 697 -702
全反式维甲酸在实体瘤中临床应用进展
全屏
[Author(id=1329529024025571782, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529024096874952, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529024025571782, language=EN, stringName=Cong RUAN, firstName=Cong, middleName=null, lastName=RUAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529024159789513, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529024025571782, language=CN, stringName=阮聪, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.复旦大学附属肿瘤医院闵行分院药剂科,上海 200240, bio={"content":"

阮聪,药师,研究方向:肿瘤内分泌药物治疗管理。

"}, bioImg=null, bioContent=

阮聪,药师,研究方向:肿瘤内分泌药物治疗管理。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529023669055929, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=1., ext=[AuthorCompanyExt(id=1329529023677444538, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023669055929, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China), AuthorCompanyExt(id=1329529023685833147, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023669055929, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属肿瘤医院闵行分院药剂科,上海 200240)])]), Author(id=1329529024231092683, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529024302395853, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529024231092683, language=EN, stringName=Jiajia QIAN, firstName=Jiajia, middleName=null, lastName=QIAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529024373699022, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529024231092683, language=CN, stringName=钱佳佳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.复旦大学附属肿瘤医院闵行分院药剂科,上海 200240, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529023669055929, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=1., ext=[AuthorCompanyExt(id=1329529023677444538, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023669055929, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China), AuthorCompanyExt(id=1329529023685833147, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023669055929, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属肿瘤医院闵行分院药剂科,上海 200240)])]), Author(id=1329529024440807888, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529024533082580, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529024440807888, language=EN, stringName=Qiong DU, firstName=Qiong, middleName=null, lastName=DU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China
2.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China
3.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529024625357269, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529024440807888, language=CN, stringName=杜琼, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.复旦大学附属肿瘤医院闵行分院药剂科,上海 200240
2.复旦大学附属肿瘤医院药剂科,上海 200032
3.复旦大学上海医学院肿瘤学系,上海 200032, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529023669055929, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=1., ext=[AuthorCompanyExt(id=1329529023677444538, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023669055929, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China), AuthorCompanyExt(id=1329529023685833147, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023669055929, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属肿瘤医院闵行分院药剂科,上海 200240)]), AuthorCompany(id=1329529023752942012, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=2., ext=[AuthorCompanyExt(id=1329529023761330621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023752942012, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China), AuthorCompanyExt(id=1329529023769719230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023752942012, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学附属肿瘤医院药剂科,上海 200032)]), AuthorCompany(id=1329529023849411007, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=3., ext=[AuthorCompanyExt(id=1329529023861993920, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023849411007, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China), AuthorCompanyExt(id=1329529023870382529, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023849411007, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.复旦大学上海医学院肿瘤学系,上海 200032)])]), Author(id=1329529024709243351, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, orderNo=3, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529024818295259, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529024709243351, language=EN, stringName=Qing ZHAI, firstName=Qing, middleName=null, lastName=ZHAI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China
2.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China
3.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529024881209820, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529024709243351, language=CN, stringName=翟青, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, 2, 3, address=1.复旦大学附属肿瘤医院闵行分院药剂科,上海 200240
2.复旦大学附属肿瘤医院药剂科,上海 200032
3.复旦大学上海医学院肿瘤学系,上海 200032, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529023669055929, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=1., ext=[AuthorCompanyExt(id=1329529023677444538, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023669055929, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China), AuthorCompanyExt(id=1329529023685833147, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023669055929, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属肿瘤医院闵行分院药剂科,上海 200240)]), AuthorCompany(id=1329529023752942012, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=2., ext=[AuthorCompanyExt(id=1329529023761330621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023752942012, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China), AuthorCompanyExt(id=1329529023769719230, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023752942012, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.复旦大学附属肿瘤医院药剂科,上海 200032)]), AuthorCompany(id=1329529023849411007, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=3., ext=[AuthorCompanyExt(id=1329529023861993920, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023849411007, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China), AuthorCompanyExt(id=1329529023870382529, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023849411007, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=3.复旦大学上海医学院肿瘤学系,上海 200032)])]), Author(id=1329529024944124382, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, orderNo=4, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329529025036399072, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529024944124382, language=EN, stringName=Xiaomin SUN, firstName=Xiaomin, middleName=null, lastName=SUN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=4, address=4.Shandong LONGFINE Pharmaceutical Co., Ltd., Jining 272600, Shandong Province China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529025128673761, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529024944124382, language=CN, stringName=孙晓敏, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=4, address=4.山东良福制药有限公司,山东 济宁 272600, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529023924908482, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=4., ext=[AuthorCompanyExt(id=1329529023933297091, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023924908482, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.Shandong LONGFINE Pharmaceutical Co., Ltd., Jining 272600, Shandong Province China), AuthorCompanyExt(id=1329529023937491396, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023924908482, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=4.山东良福制药有限公司,山东 济宁 272600)])]), Author(id=1329529025195782627, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, orderNo=5, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329529025271280101, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529025195782627, language=EN, stringName=Rui XU, firstName=Rui, middleName=null, lastName=XU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329529025346777574, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, authorId=1329529025195782627, language=CN, stringName=徐蕊, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, *, address=1.复旦大学附属肿瘤医院闵行分院药剂科,上海 200240, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329529023669055929, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, xref=1., ext=[AuthorCompanyExt(id=1329529023677444538, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023669055929, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China), AuthorCompanyExt(id=1329529023685833147, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329529021777424822, companyId=1329529023669055929, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.复旦大学附属肿瘤医院闵行分院药剂科,上海 200240)])])]
阮聪1, 钱佳佳1, 杜琼1, 2, 3, 翟青1, 2, 3, 孙晓敏4, 徐蕊1, *
作者信息
  • 1.复旦大学附属肿瘤医院闵行分院药剂科,上海 200240
  • 2.复旦大学附属肿瘤医院药剂科,上海 200032
  • 3.复旦大学上海医学院肿瘤学系,上海 200032
  • 4.山东良福制药有限公司,山东 济宁 272600
通讯作者:
徐蕊,主管药师,研究方向:肿瘤药学。
作者简介:

阮聪,药师,研究方向:肿瘤内分泌药物治疗管理。

Progress in the clinical application of all-trans-retinoic acid in solid tumors
Cong RUAN1, Jiajia QIAN1, Qiong DU1, 2, 3, Qing ZHAI1, 2, 3, Xiaomin SUN4, Rui XU1, *
Affiliations
  • 1.Department of Pharmacy, Fudan University Shanghai Cancer Center Minhang Branch, Shanghai 200240, China
  • 2.Department of Pharmacy, Fudan University Shanghai Cancer Center, Shanghai 200032, China
  • 3.Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
  • 4.Shandong LONGFINE Pharmaceutical Co., Ltd., Jining 272600, Shandong Province China
出版时间: 2024-07-10 doi: 10.13683/j.wph.2024.07.001
文章导航
收藏切换

全反式维甲酸(all-trans-retinoic acid,ATRA)是治疗急性早幼粒细胞白血病(acute promyelocytic leukemia)的临床首选药物。然而近年来大量研究表明,ATRA可通过抑制肿瘤干细胞的免疫逃逸效应以及促进髓源性抑制细胞的分化等机制来维持人体正常免疫微环境,进而增强化疗、靶向和免疫治疗药物在实体瘤中的疗效。该文就ATRA在实体瘤中的临床研究进展作一综述,为其进一步临床应用提供参考。

全反式维甲酸  /  实体瘤  /  肿瘤干细胞  /  髓源性抑制细胞  /  免疫调节

All-trans-retinoic acid (ATRA) is the clinical choice for the treatment of acute promyelocytic leukemia. However, in recent years, a large number of studies have shown that ATRA maintains the human normal immune microenvironment by inhibiting the immune escape effect of tumor stem cells and promoting the differentiation of myeloid-derived suppressor cells, and enhances the efficacy of chemotherapeutic drugs, targeted drugs and immunotherapy drugs in solid tumors. This paper reviewed the clinical trial progress of ATRA in solid tumors to provide a reference for its further clinical application.

all-trans-retinoic acid  /  solid tumor  /  tumor stem cells  /  myeloid-derived suppressor cells  /  immunomodulation
阮聪, 钱佳佳, 杜琼, 翟青, 孙晓敏, 徐蕊. 全反式维甲酸在实体瘤中临床应用进展. 世界临床药物, 2024 , 45 (7) : 697 -702 . DOI: 10.13683/j.wph.2024.07.001
Cong RUAN, Jiajia QIAN, Qiong DU, Qing ZHAI, Xiaomin SUN, Rui XU. Progress in the clinical application of all-trans-retinoic acid in solid tumors[J]. World Clinical Drug, 2024 , 45 (7) : 697 -702 . DOI: 10.13683/j.wph.2024.07.001
  • 上海市闵行区卫生健康系统优秀青年药学人才计划(MWYJYX03)
  • 上海市闵行区自然科学研究课题(2022MHZ040)
参考文献 引证文献
排序方式:
[1]
Gudas LJ. Retinoids retinoic acid receptors and cancer[J]. Toxicology, 2001, 164(1-3): 11.
[2]
Huang ME, Ye YC, Chen SR, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia[J]. Blood, 1988, 72(2): 567-572.
[3]
Lei MML, Lee TKW. Cancer stem cells: emerging key players in immune evasion of cancers[J]. Front Cell Dev Biol, 2021, 9: 692940.
[4]
Chulpanova DS, Rizvanov AA, Solovyeva VV. The role of cancer stem cells and their extracellular vesicles in the modulation of the antitumor immunity[J]. Int J Mol Sci, 2022, 24(1): 395.
[5]
Zhao J. Cancer stem cells and chemoresistance: the smartest survives the raid[J]. Pharmacol Ther, 2016, 160: 145-158.
[6]
Moreb JS, Ucar-Bilyeu DA, Khan A. Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells[J]. Cancer Chemothe Pharmacol, 2017, 79(2): 295-301.
[7]
Bi G, Liang J, Bian Y, et al. The immunomodulatory role of all-trans retinoic acid in tumor microenvironment[J]. Clin Exp Med, 2023, 23(3), 591-606.
[8]
Nefedova Y, Fishman M, Sherman S, et al. Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells[J]. Cancer Res, 2007, 67(22): 11021-11028.
[9]
Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023[J]. CA Cancer J Clin, 2023, 73(1): 17-48.
[10]
Makowski P, Pacholczyk M, Agiewska B, et al. Hepatocellular carcinoma-epidemiology and treatment[J]. Przegl Epidemiol, 2006, 60(4): 731-740.
[11]
Belghiti J, Kianmanesh R. Surgical treatment of hepatocellular carcinoma[J]. HPB (Oxford), 2005, 7: 42-49.
[12]
Lee PH, Lin WJ, Tsang YM, et al. Clinical management of recurrent hepatocellular carcinoma[J]. Ann Surg, 1995, 222(5): 670-676.
[13]
Tanaka S, Arii S. Molecularly targeted therapy for hepatocellular carcinoma[J]. Cancer Sci, 2009, 100(1): 1-8.
[14]
Zhang Y, Guan DX, Shi J, et al. All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancer[J]. J Hepatol, 2013, 59(6): 1255-1263.
[15]
Sun J, Liu H, Shi J, et al. All-trans retinoic acid combined with oxaliplatin suppressed proliferation of chemo-resistant hepatocellular carcinoma cells by inducing G2/M cell cycle arrest[J]. Termedia Publishing House, 2021.
[16]
Sun J, Liu C, Shi J, et al. A novel chemotherapy strategy for advanced hepatocellular carcinoma: a multicenter retrospective study[J]. Chin Med J (Engl), 2022, 135(19): 2338-2343.
[17]
Sun J, Liu C, Wang N, et al. All-trans-retinoic acid plus oxaliplatin/fluorouracil/leucovorin for advanced hepatocellular carcinoma with pulmonary metastasis: a multicenter retrospective study[J]. Cancer Manag Res, 2022, 14: 1663-1670.
[18]
Ghosn M, Kourie HR, El Karak F, et al. Optimum chemotherapy in the management of metastatic pancreatic cancer[J]. World J Gastroenterol, 2014, 20(9): 2352-2357.
[19]
Ohmine K, Kawaguchi K, Ohtsuki S, et al. Quantitative targeted proteomics of pancreatic cancer: deoxycytidine kinase protein level correlates to progression-free survival of patients receiving gemcitabine treatment[J]. Mol Pharm, 2015, 12(9): 3282-3291.
[20]
Kuroda H, Tachikawa M, Uchida Y, et al. All-trans retinoic acid enhances gemcitabine cytotoxicity in human pancreatic cancer cell line AsPC-1 by up-regulating protein expression of deoxycytidine kinase[J]. Eur J Pharm Sci, 2017, 30: 116-121.
[21]
Kocher HM, Basu B, Froeling FEM, et al. Phase Ⅰ clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer[J]. Nat Commun, 2020, 11(1): 4841.
[22]
Nguyen PH, Giraud J, Staedel C, et al. All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth[J]. Oncogene, 2016, 35(43): 5619-5628.
[23]
胡孔旺, 孟翔凌, 杨文奇, 等. 全反式维甲酸及腹腔化疗对进展期胃癌手术后患者生存期的影响[J]. 肿瘤, 2013, 33(6): 550-555.
[24]
Lieberman DA, Rex DK, Winawer SJ, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer[J]. Gastroenterology, 2012, 143(3): 844-857.
[25]
Guinney J, Dienstmann R, Wang X, et al. The consensus molecular subtypes of colorectal cancer[J]. Nat Med, 2015, 21(11): 1350-1356.
[26]
Liu W, Song Y, Zhang C, et al. The protective role of all-transretinoic acid (ATRA) against colorectal cancer development is achieved via increasing miR-3666 expression and decreasing E2F7 expression[J]. Biomed Pharmacother, 2018, 104: 94-101.
[27]
尤振宇, 刘洋, 苏晓辉, 等. 全反式维甲酸联合化疗治疗晚期结肠癌临床观察[J]. 现代生物医学进展, 2015, 15(13): 2478-2482.
[28]
Kleiner DE, Stetler-Stevenson WG. Matrix metalloproteinases and metastasis[J]. Cancer Chemother Pharmacol, 1999, 43(Suppl): S42-S51.
[29]
Dutta A, Sen T, Banerji A, et al. Studies on multifunctional effect of all-trans retinoic acid (ATRA) on matrix metalloproteinase-2 (MMP-2) and its regulatory molecules in human breast cancer cells (MCF-7)[J]. J Oncol, 2009, 2009: 627840.
[30]
Bryan M, Pulte ED, Toomey KC, et al. A pilot phase Ⅱ trial of all-trans retinoic acid (Vesanoid) and paclitaxel (Taxol) in patients with recurrent or metastatic breast cancer[J]. Invest New Drugs, 2011, 29(6): 1482-1487.
[31]
Manna SK, Aggarwal BB. All-trans-retinoic acid upregulates TNF receptors and potentiates TNF-induced activation of nuclear factors-κB, activated protein-1 and apoptosis in human lung cancer cells[J]. Oncogene, 2000, 19(17): 2110-2119.
[32]
Moro M, Bertolini G, Pastorino U, et al. Combination treatment with all-trans retinoic acid prevents cisplatin-induced enrichment of CD133+ tumor-initiating cells and reveals heterogeneity of cancer stem cell compartment in lung cancer[J]. J Thorac Oncol, 2015, 10(7): 1027-1036.
[33]
Conley BA, Egorin MJ, Sridhara R, et al. Phase Ⅰclinical trial of all-trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamics[J]. Cancer Chemother Pharmacol, 1997, 39(4): 291-299.
[34]
Arrieta O, González-De la Rosa CH, Aréchaga-Ocampo E, et al. Randomized phase Ⅱ trial of All-trans-retinoic acid with chemotherapy based on paclitaxel and cisplatin as first-line treatment in patients with advanced non-small-cell lung cancer[J]. J Clin Oncol, 2010, 28(21): 3463-3471.
[35]
Kokemueller H, Eckardt A, Brachvogel P, et al. Adenoid cystic carcinoma of the head and neck-a 20 years experience[J]. Int J Oral Maxillofac Surg, 2004, 33(1): 25-31.
[36]
Lloyd S, Yu JB, Wilson LD, et al. Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy[J]. Am J Clin Oncol, 2011, 34(1): 76-81.
[37]
Ellington CL, Goodman M, Kono SA, et al. Adenoid cystic carcinoma of the head and neck: incidence and survival trends based on 1973—2007 surveillance, epidemiology, and end results data[J]. Cancer, 2012, 118(18): 4444-4451.
[38]
Dillon PM, Chakraborty S, Moskaluk CA, et al. Adenoid cystic carcinoma: a review of recent advances, molecular targets, and clinical trials[J]. Head Neck, 2016, 38(4): 620-627.
[39]
Mandelbaum J, Shestopalov IA, Henderson RE, et al. Zebrafish blastomere screen identifies retinoic acid suppression of MYB in adenoid cystic carcinoma[J]. J Exp Med, 2018, 215(10): 2673-2685.
[40]
Hanna GJ, ONeill A, Cutler JM, et al. A phase Ⅱ trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma[J]. Oral Oncol, 2021, 119: 105366.
[41]
Ye L, Zhang L, Li R, et al. Combined all-trans retinoic acid with low-dose apatinib in treatment of recurrent/metastatic head and neck adenoid cystic carcinoma: a single-center, secondary analysis of a phase Ⅱ study[J]. Cancer Med, 2023, 12(8): 9144-9155.
[42]
Tobin RP, Jordan KR, Robinson WA, et al. Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with ipilimumab[J]. Int Immunopharmacol, 2018, 63: 282-291.
[43]
Tobin RP, Cogswell DT, Cates VM, et al. Targeting MDSC differentiation using ATRA: a phase Ⅰ/Ⅱ clinical trial combining pembrolizumab and all-trans retinoic acid for metastatic melanoma[J]. Clin Cancer Res, 2023, 29(7): 1209-1219.
2024年第45卷第7期
21
7
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2024.07.001
  • 接收时间:2023-07-23
  • 首发时间:2026-11-17
  • 出版时间:2024-07-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-07-23
  • 修回日期:2023-08-08
基金
上海市闵行区卫生健康系统优秀青年药学人才计划(MWYJYX03)
上海市闵行区自然科学研究课题(2022MHZ040)
作者信息
    1.复旦大学附属肿瘤医院闵行分院药剂科,上海 200240
    2.复旦大学附属肿瘤医院药剂科,上海 200032
    3.复旦大学上海医学院肿瘤学系,上海 200032
    4.山东良福制药有限公司,山东 济宁 272600

通讯作者:

徐蕊,主管药师,研究方向:肿瘤药学。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2024.07.001
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏